[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update].Clin Calcium. 2011 Dec; 21(12):123-43.CC
Abstract
The outline of Japanese Guideline for the prevention and treatment of Osteoporosis (up dated 2011) was introduced. Descriptions were made on the identification of risk factors for fracture, prevention of osteoporosis, criteria for initiating pharmacotherapy to prevent fracture. Grading of recommendation for medication based on evidence, introduction of bone turnover markers in the treatment and secondary osteoporosis.
MeSH
Pub Type(s)
English Abstract
Journal Article
Review
Language
jpn
PubMed ID
22133832
Citation
Orimo, Hajime. "[Bone and Calcium Update; Diagnosis and Therapy of Metabolic Bone Disease Update. Guideline for Prevention and Treatment of Osteoporosis Update]." Clinical Calcium, vol. 21, no. 12, 2011, pp. 123-43.
Orimo H. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update]. Clin Calcium. 2011;21(12):123-43.
Orimo, H. (2011). [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update]. Clinical Calcium, 21(12), 123-43. https://doi.org/CliCa111218731893
Orimo H. [Bone and Calcium Update; Diagnosis and Therapy of Metabolic Bone Disease Update. Guideline for Prevention and Treatment of Osteoporosis Update]. Clin Calcium. 2011;21(12):123-43. PubMed PMID: 22133832.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update].
A1 - Orimo,Hajime,
PY - 2011/12/3/entrez
PY - 2011/12/3/pubmed
PY - 2012/2/15/medline
SP - 123
EP - 43
JF - Clinical calcium
JO - Clin Calcium
VL - 21
IS - 12
N2 - The outline of Japanese Guideline for the prevention and treatment of Osteoporosis (up dated 2011) was introduced. Descriptions were made on the identification of risk factors for fracture, prevention of osteoporosis, criteria for initiating pharmacotherapy to prevent fracture. Grading of recommendation for medication based on evidence, introduction of bone turnover markers in the treatment and secondary osteoporosis.
SN - 0917-5857
UR - https://www.unboundmedicine.com/medline/citation/22133832/[Bone_and_calcium_update
L2 - http://www.diseaseinfosearch.org/result/9059
DB - PRIME
DP - Unbound Medicine
ER -